You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for New Drug Application (NDA): 021487


✉ Email this page to a colleague

« Back to Dashboard


NDA 021487 describes NAMENDA, which is a drug marketed by Allergan and Abbvie and is included in three NDAs. It is available from four suppliers. There is one patent protecting this drug and five Paragraph IV challenges. Additional details are available on the NAMENDA profile page.

The generic ingredient in NAMENDA is memantine hydrochloride. There are twenty-eight drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the memantine hydrochloride profile page.
Summary for 021487
Tradename:NAMENDA
Applicant:Abbvie
Ingredient:memantine hydrochloride
Patents:0
Pharmacology for NDA: 021487
Mechanism of ActionNMDA Receptor Antagonists
Medical Subject Heading (MeSH) Categories for 021487
Suppliers and Packaging for NDA: 021487
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NAMENDA memantine hydrochloride TABLET;ORAL 021487 NDA Allergan, Inc. 0456-3200 0456-3200-14 1 KIT in 1 BLISTER PACK (0456-3200-14)
NAMENDA memantine hydrochloride TABLET;ORAL 021487 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-3870 0591-3870-44 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0591-3870-44) / 10 TABLET in 1 BLISTER PACK (0591-3870-45)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Oct 16, 2003TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Oct 16, 2003TE:ABRLD:Yes

Expired US Patents for NDA 021487

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie NAMENDA memantine hydrochloride TABLET;ORAL 021487-002 Oct 16, 2003 ⤷  Sign Up ⤷  Sign Up
Abbvie NAMENDA memantine hydrochloride TABLET;ORAL 021487-001 Oct 16, 2003 ⤷  Sign Up ⤷  Sign Up
Abbvie NAMENDA memantine hydrochloride TABLET;ORAL 021487-002 Oct 16, 2003 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.